# FDA recall D-0926-2023

> **New England Life Care, Inc. dba Advanced Compounding Solutions** · Class II · drug recall initiated 2023-07-10.

## Product

SUCCINYLcholine Chloride 200 mg/10mL (20 mg/mL), 10 mL BD Syringe, Rx Only, Advanced Compounding Solutions, 4 Constitution Way Ste L Woburn, MA 01801-1042; NDC: 71546-083-10

## Reason for recall

CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0926-2023
- **Recalling firm:** New England Life Care, Inc. dba Advanced Compounding Solutions
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-07-10
- **Report date:** 2023-07-26
- **Termination date:** 2023-12-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Woburn, MA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0926-2023

## Citation

> AI Analytics. FDA recall D-0926-2023. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0926-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*